The present invention relates to a reactor for chemical synthesis.
Since the first report of solid-phase synthesis of peptides by Merrifield in 1962, several applications of using solid matrices have evolved over the past 50 years. For example, solid-phase synthesis is now routinely employed for the synthesis and manufacture of macromolecules such as peptides, carbohydrates, and di-, tri- or larger oligonucleotides.
Also, several organic reactions are routinely performed in solution phase employing reagents that are covalently bound to solid matrix. Following the reaction, the matrix containing the reagent is simply filtered off from the reaction medium enabling partial purification of the desired product from the solution. In another application, compounds attached to solid matrices that carry acidic and basic moieties are employed as “scavengers” of basic and acidic reagents respectively from reaction media.
Several catalysts employed in organic synthesis are often used as solid matrix. Compounds attached to solid matrices are also employed as sensors in detection devices. In yet another application, drug molecules attached to solid matrices are used as delivery systems for topical and systemic administration of drugs.
Macromolecules such as oligonucleotides as antisense compounds and as agents of RNA interference and peptides are synthesized and manufactured routinely using solid-phase synthesis. In this case, the first nucleotidic or amino acid residue (also referred to as the leader building block) is covalently attached to the solid matrix via a linker arm. The subsequent additions of monomeric units to the leader building block is carried out on the solid matrix. Upon completion of the assembly of the macromolecule, the matrix is treated with a reagent that cleaves the linker arm of the leader block thereby releasing the macromolecule into solution.
Many of these reactions are carried out using reagents that are sensitive to air and/or moisture. This is accomplished by operating the reactions in an inert atmosphere of argon or nitrogen in a closed reaction vessel such as a column. The column usually has a cylindrical configuration with the two ends of the cylinder carrying filters that hold the solid support within the body of the cylinder. The reactants are introduced into the column via inert gas pressure and the reaction takes place within the vessel between the leader monomer unit and the reactant.
In such multi-phase reactions where one or more components is a solid, liquid, or gas, proper contact between the phases is critical in ensuring efficient reactions that result in high yields. Often, an excess of reactants is required to be employed for ensuring that reactions go to completion. In addition, a continuous flow of inert gas needs to be maintained for achieving a state of “fluidization” so that intermixing of phases occurs. The excess reagents cannot be readily recovered resulting in wasteful processes and increased costs of a given operation.
Furthermore, since the reaction vessel is a closed assembly, access to the solid matrix during the reaction can only be made by opening the vessel and interrupting the reaction. Access to solid matrix is important because it will facilitate the determination of the physical changes of the matrix such as changes in swelling characteristics, particle size, pore size etc and allow for more efficient control of the reaction. In closed assemblies, the reactions can be monitored only by downstream sampling of the liquid exiting from the reactor. Indeed, for some synthetic steps, in a solid-phase reaction, it is preferable to directly analyze the solid matrix rather than relying exclusively on downstream sampling of the column effluent.
The present invention overcomes the above-described drawbacks in the state of the art reactors for chemical synthesis. The present invention relates to the design and use of a multipurpose reactor that may be adapted to accommodate a wide variety of solid phase and liquid phase reaction chemistries.
The present invention will become more fully understood from the detailed description given herein below and the accompanying drawing which is given by way of illustration only, and thus, is not limitative to the present invention. In the following drawings, like reference characters designate the same or similar parts throughout the several views, and wherein:
The multipurpose reactor of the invention has unique design features, and enables simultaneous and efficient mixing of solid, liquid and gas phases for a variety of applications in solid and/or liquid phase reaction chemistries.
The upper chamber further comprises a gas/liquid/solid inlet 16. The gas/fluid inlet 16 may optionally be designed to connect to another device in an airtight manner via a suitable adapter. For example, if the reaction vessel is a glass assembly, the opening can be a 24/40-glass joint that can fit into a 24/40 gas bubbling device. Alternatively, the opening can be fitted with septa through which inert gas or liquid or solid can be introduced into the reactor. Generally, the inlet 16 is used to introduce fresh chemical reactants into the reaction vessel and to admit pressurized inert gasses into the reaction chamber to facilitate chemical reactions while maintaining an airtight inert gas atmosphere in the reaction vessel 1.
Pressure relief means are generally associated with the upper chamber 10 or the lower chamber 12 of the reaction vessel. Preferably, pressure relief means 18 are associated with the upper chamber as is shown in
The lower chamber 12 is equipped with a filter unit 22 which comprises a filter 24 which may be a membrane filter, a polypropylene mesh, or a frit (of suitable pore size) and a filter support means 26 which may be a mesh, grid or other support that may be fixed to the wall of the lower chamber 12 and is capable of supporting the filter 24 and a solid-phase or solution-phase synthesis of a chemical above the filter 24 while allowing reagents to pass below the filter unit 22. Alternatively, the filter unit 22 can be designed to be a false bottom unit integrated into a “pull away” or “pull down” module, or alternatively a diaphragm, which can be opened or closed as needed. These latter designs allow the solid matrix to be washed out of the reaction vessel and facilitate more efficient cleaning of the vessel.
In the case of solid-phase synthesis, a solid matrix used in the reaction can be placed on top of the filter 24 and the filter unit 22. The chemical product assembly occurs on the solid matrix via a series of step-wise reaction sequences involving reactants added to the reaction vessel at appropriate times, preferably through the inlet 16 of the upper chamber 10. At the end of the reaction, the solid matrix can be removed by separating the upper chamber 10 and the lower chamber 12 and accessing the lower chamber for removal of the solid matrix. The chemical product can then be isolated from the solid matrix. Alternatively, the use of false bottom or diaphragm design as the filter unit 22, allows the matrix to be emptied as slurry into a collection reservoir 28 in solid/liquid/gas and gas contact with the lower chamber as shown in
The lower chamber 12, may further comprise an adapter 30 for providing an airtight connection to the collection reservoir 28, and the adapter 30 may further comprise a collection reservoir switch means 32 for preventing or allowing solid/liquid/gas to enter the collection reservoir 28 from the lower chamber 12. The adapter 30 may also further comprise a gas port 38 suitable for connecting to a vacuum line or other means for creating a draw in the lower chamber 12 to draw reactants and excess reagents through the lower chamber 12 from above the filter means 22 to below the filter means 22 and into the collection reservoir 28 as desired.
The collection reservoir may further comprise a collection reservoir port 40 that may be used for drawing reactants and excess reagents into the reservoir or for collecting the contents of the reservoir 28.
The lower chamber 12 optionally comprises a sampling port 34 that allows a sample of solid matrix to be drawn for analysis during the chemical reaction. Liquid reactants can also be sampled from port 34. The sampling port 34 may comprise a sampling port switch means 36 capable of being opened and closed to allow access to the chemical reaction mixture in the lower chamber 12.
Optionally, the entire reaction vessel shown in
In one aspect of the invention as shown in
The pump 48 has at least two pump heads 58 and 60 that serve two functions (a) it helps draw the reactants reservoir 52 contents into the reaction vessel via the reactant conduit means 54 connected through the gas/solid/liquid/gas inlet port 16 via pump head 60 and (b) it helps in recycling the contents of the reaction vessel 1 through recycled reagent ports 44 and 42 via pump head 58. The pump 48 may optionally be connected to a flow controller 56 that may be used to modulate the delivery of reagent or the rate of recycling throughout the reaction vessel in order to maximize chemical reactions occurring in the reaction vessel. The concept of recycling the liquid phases in the vessel serves multiple objectives including helping to ensure efficient intermixing and contact between the liquid, solid, and gaseous phase for fast and efficient reactions, and helping to minimize reagent consumption in the reaction. The recycling can be done in both forward, as well as, reverse directions, at different speeds. Forward recycling generates turbulent forces that help in the mixing of solid and liquid phases thereby aiding mixing. The combined fluid actives of forward and reverse recycling facilitates thorough mixing of the solid and liquid reaction phases thereby resulting in rapid reaction kinetics and highly efficient synthesis without causing mechanical abrasion of solid support.
The pump 48 is preferably a peristaltic pump but can also be a vacuum pump or any other pump suitable for use with the subject devices and methods of the present invention.
The entire chemical reaction process incorporating the reactor of the invention can be automated as known in the art. For example, a programmable electronic control unit may be added to the reactor system shown in
The reaction vessel of the invention may also be adapted with a “shower head distributor” (SHD) 80 (shown in
The reactor of the invention may be adapted to accommodate a wide variety of solid phase, liquid phase and combination solid/liquid phase reaction chemistries. Examples of such chemistries include, but are not limited to: large-scale purification of recombinant proteins, monoclonal antibodies, and their conjugates using affinity chromatography, ion-exchange chromatography, and size-exclusion chromatography; manufacture of nucleic acids, peptides, and carbohydrates by solid-phase methodologies; solid-, and solution-phase combinatorial synthesis of small molecules for drug discovery, as well as, manufacture of small molecules; preparation of functionalized solid matrices such as beads, films, and pins carrying different types of ligands, such functionalized solid matrices find extensive use as (a) sensors in detection devices, (b) natural product extractions, (c) scavenging ligands in environmental clean up of toxic materials, (d) biomedical media for Radio-immuno assays, Fluorescent immuno-assays, ELISA, affinity chromatography and size exclusion chromatography; and (e) Drug delivery systems for topical and systemic administration of drugs.
In one embodiment, the reaction vessel 1 contains a solid phase polymer resin dispensed on the filter unit 22 of the lower chamber 12, preferably a solid phase peptide synthesis resin, such as crossed linked polystyrene. In some embodiments, the vessel is adapted to large scale synthesis, and/or contains at least 10, preferably at least 100, more preferably at least 1,000, more preferably at least 10,000 g resin (dry weight). Such embodiments are capable of simultaneously activating and coupling 100 g amino acid per step and provide yields of from 100 to 5,000 g of protected decapeptides. Solid phase polymer synthesis reaction chemistries are widely known in the art. For example, a typical peptide synthesis is conducted by the following procedure: The N-terminus of the resin-bound amino acid, peptide (protected by FMOC) is deblocked in a solution of piperidine in dimethyl formamide (DMF), for example. The next amino acid in the sequence is coupled to the resin-bound peptide with coupling agent such as dicyclohexylcarbodiimide (DCC), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexaflurophosphate (HBTU) in a solution of DMF, for example. An activating agent such as 1-hydroxybenzotrazole (HOBt) may be used to improve rate and selectivity of the coupling reaction and to decrease racemization. The unreacted amino acid, reagents, and by-products are removed from the resin by washing and filtration. The washing and filtration process is then repeated. The N-terminus of the peptide is then deblocked; another amino acid is added to the chain, the system is then washed and filtered, etc. The process is repeated until all the desired amino acids have been added to the peptide chain in the desired order. The remaining blocking groups are then removed from the peptide, the peptide is cleaved from the resin, and the peptide is collected.
In another embodiment, the reaction vessel 1 contains a solid phase support dispensed on the filter unit 22 of the lower chamber 12, preferably a solid phase synthesis resin, such as crossed-linked polystyrene, or controlled-pore-glass (CPG) linked to a leader nucleoside. In more particular embodiments, the vessel is adapted to large scale synthesis, and/or contains at least 10, preferably at least 100, more preferably at least 1,000, more preferably at least 10,000 g of support (dry weight). Such embodiments are capable of simultaneously activating and coupling 100 g nucleoside phosphoramidites or H-phosphonates per step and provide yields from 100 to 5,000 g of polynucleotides following the synthesis cycle steps consisting of detritylation, coupling, capping and oxidation or sulfurization.
Such solid phase polymer synthesis reaction chemistries for the synthesis of polynucleotides are widely known in the art. For example, a typical polynucleotide synthesis is conducted by the following procedure: The 5′-O-4,4-dimethoxytrityl (DMT) group of the support-bound nucleoside is deblocked in a solution of dichloroacetic acid in dichloromethane (DCM), for example. The next nucleotide in the sequence is coupled to the support-bound nucleoside via the corresponding nucleoside 5′-O-DMT-3′-O-β-betacyanoethyl-phosphoramidite using a coupling agent such as 1H-tetrazole, ethylthiotetrazole, 4,5-dicyanoimidazole, or benzimidazolium trifluromethane sulfonate etc. The unreacted phosphoramidites, reagents, and by-products are removed from the support by washing and filtration. The washing and filtration process is then repeated. The resulting internucleotidic phosphite is then oxidized (iodine/pyridine/water) or sulfurized (3H-benzodithiole-3-one-1,1-dioxide) resulting in the formation of phosphotriester or thiophosphotriester linkage. The 5′-O-DMT-terminus of the coupled product is then deblocked, another nucleoside phosphoramidite is added to the chain, and the synthetic sequence repeated until all the desired nucleoside units have been added to the polynucleotide chain in the desired order.
Following the assembly of the polynucleotide, the support is removed from the reactor vessel and deprotection and cleavage reactions are carried out to obtain the polynucleotide free in solution. In a typical protocol for deprotection, the solid support containing polynucleotide is treated with aq. NH4OH and heated at 55° C. for 12 h. The deprotection is monitored by analytical HPLC and after completion of deprotection, the solid support is filtered, washed with water and the aqueous solution is acidified with acetic acid to pH 6.5-7.0. The crude compound is purified by preparative HPLC to isolate pure polynucleotide directly as its ammonium salt. Phosphorothioate polynucleotide typically has 31P-NMR, δ 55-56 ppm.
In an another aspect of the invention, the reactor of the invention as exemplified in
In yet another embodiment, the reactor shown in
As shown in
As opposed to the current technology of static-bed chromatography, in the case of the reactor of the invention shown in
Additionally, the following features of the reactor of the invention will help advance different modalities in the practice of chromatography.
For affinity chromatography and ion exchange chromatography:
For size-exclusion chromatography: only forward recycling will be used to help increase height equivalent to a theoretical plate (HETP) and facilitate separation between proteins of very close molecular weight. This strategy will ensure that during recycling, the fast-moving protein band of high molecular weight is not allowed to go back to the column but is collected via sampling port as it reaches the bottom of the column. Different approaches may be used to ascertain elution of the protein: (a) using dyes of different molecular weights that serve as positional molecular weight markers, and (b) by employing a UV detection for the eluent. It is possible that in certain circumstances a cylindrical column configuration such as that shown in
The design features of the reactor of the invention adapted for use in chromatography make it a versatile system for conducting large-scale purifications of biomolecules using chromatographic methods. Example 4 describes the use of the reactor of the invention for the isolation and purification of a recombinant proteint, OP-1 (a bone morphogenic protein) from cell media.
As a representative example, we carried out the loading of 5′-O-4,4-dimethoxytriyl-N-benzoyl-deoxyadenosine (DMT-NBzdA) and 5′-O-4,4-dimethoxytrityl thymidine (DMT-T) on succinylated CPG, using the reactor of the invention in conjunction with anhydrous DMF as solvent. Using 100 g supports in each batch, we were able to achieve high nucleoside loading of 70 to 80 μmol/g with only three equivalents of nucleoside within 12 to 14 hours. Both filtration and drying operations were performed in LOTUS. The nucleoside-loaded CPG was then treated with CAP A and CAP B in the reactor. Following orbital shaking coupled with active recycling, the reaction mixture was filtered, washed and dried. Thus, the nucleoside loading, as well as, the attendant process operations could be conveniently performed in reactor of the invention. Additionally, the use of DMF instead of pyridine prevented any unpleasant odor and also aided the facile recovery of excess nucleoside, which is especially advantageous while using expensive nucleosides. Indeed, the recovery of excess nucleoside was carried out by simple aqueous work-up of the DMF filtrate. Subsequently, the recovered nucleosides (DMT-NBzdA) were successfully loaded onto succinylated CPG. We believe that efficient intermixing of phases, induced by orbital shaking coupled with active recycling, along with on-line monitoring, is the key to faster reactions and dramatically improved nucleoside loading on solid support using the reactor of the invention.
It is pertinent to mention that nucleoside loading on succinylated CPG could also be carried out by simple orbital shaking using DMF as a solvent. Thus, we carried out loading on succinylated CPG (100 g batches) using five equivalents of DMT-NBzdA and DMT-T. Using this procedure, nucleoside-loaded CPG with loadings ranging from 60 to 70 micromol/g could be obtained. Using similar procedures, we have also carried out nucleoside loadings on carboxy-terminated wide-pore silica, Tentagel, and aminomethyl polystyrene.
Materials. DMT-NBzdA and DMT-T were obtained from Reliable Biopharmaceuticals (Mo.) and used as such. Anhydrous pyridine and dimethylformamide from reputed vendors were freshly distilled from CaH2 prior to use. CPG was obtained from Prime Synthesis (Pa.). Other reagents such as EDC, N,N-Dimethylaminopyridine (DMAP), and triethylamine were obtained from reputed vendors and used as such. Cap A and Cap B were obtained from American International Chemicals (Mass.).
We tested the use of the reactor of the invention in the solid-phase synthesis of a dinucleotide 5′-U2′-OMe dA3′ using the synthesis protocol described previously. The HPLC profile of the crude showed (data not shown) less than 2% unreacted dA nucleoside where as that prepared using an Expedite synthesizer gave variable amounts of unreacted dA in synthesis. Considering that 2′-OMeU phosphoramidite is a hindered nucleoside, the high efficiency synthesis of the dinucleotide using the reactor of the invention represents a very significant step in solid phase synthesis, particularly of oligonucleotides. Excess phophoramidite was recovered and CPG was recycled after functionalization.
In order to demonstrate the utility of the reactor of the invention and the concept of orbital shaking coupled with active recycling in purification of molecules, we purified the crude dinucleotide of Example 2. For this purpose, the commercially available Bonda Pak C-18 resin (33 g) was loaded in the reactor. By using the orbital shaking coupled with active recycling concept, the material was packed in the reactor chamber by washing with a few column volumes (2×200 mL) of water. The crude (5 millimol) was loaded on to the column. Elution was carried out with water followed by water/acetonitrile, 95/5; water/acetonitrile, 85/15; and water/acetonitrile 70/30 and 100% CH3CNeach 200 mL volume. Each eluent was collected via the recycling port, and a sample analyzed by reversed-phase HPLC (data not shown).
A number of initial experiments will be carried out to optimize parameters such as rpm of shaker, recycle flow rate, and volume, bed volume to weight of crude protein. For expanded bed, ion-exchange chromatography, four to five commercially available rainbow molecular weight markers in the Mr range of 10000 to 250000 may be used. To determine optimal resin to OP-1 protein ratio, adsorption isotherm experiments will be performed as described8. Briefly, protein solution will be prepared in 10 mM sodium acetate buffer (pH 7.0, 2M NaCl) filtered through 0.45 um membrane filter. Equal volume of different concentration of buffered protein solution will be added to a series of flasks containing 1:5 v/v suspension of the resin. The flasks will be incubated by shaking for 2 h at 25° C. (120 rpm) for equilibrium to be established. Aliquots of the solution will be filtered through a 0.45 um filter and protein concentration of supernatant determined using UV at 280 nM. Amount of bound protein will be determined by mass balance. For size exclusion chromatography, a dye kit will be used of blue Dextran 2000 (MW, 2,000,000), Yellow Dextran (20,000) and vitamin B12 molecular weight of 1,357) (both available with Amersham Biosciences).
The following steps are exemplary of the purification protocol that will be followed for OP-1 using the reactor of the invention as shown in any one of
Step 1. Pack the reactor column uniformly with ion exchange resin (Expanded bed chromatography) using orbital shaking coupled with active recycling.
Step 2. Introduce the cell media containing the target protein OP-1, through the bottom port using recycle pump and recycle the media through the bed.
Step 3. Carry out elution of the protein employing orbital shaking coupled with active recycling as desired.
Step 4. Monitor eluent by UV and combine fractions using Western blot
Step 5. Combine OP-1 fractions, desalt by membrane filtration
Step 6. Carry out size exclusion chromatography using LOTUS: (a) Introduce the OP-1 fractions from step 5 tagged with marker dyes into LOTUS packed with resin. (b) Perform forward recycle. (c) Carry out elution, collect fractions by UV monitoring, combine fractions using western blot. (d) Lyophilize OP-1 fractions to obtain product.
The OP-1 thus obtained will be evaluated in a functional assay. The results (yield, and purity) of this simplified isolation and purification protocol will be compared with that currently used for OP-1
The patent and scientific literature referred to herein establishes the knowledge that is available to those with skill in the art. All United States patents and published or unpublished United States patent applications cited herein are incorporated by reference. All published foreign patents and patent applications cited herein are hereby incorporated by reference. All other published references, documents, manuscripts and scientific literature cited herein are hereby incorporated by reference.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
This application claims the benefit of U.S. Provisional Application No. 60/574,465, filed on May 26, 2004, U.S. Provisional Application No. 60/583,414, filed on Jun. 28, 2004, U.S. Provisional Application No. 60/626,597, filed on Nov. 10, 2004 and U.S. Provisional Application No. 60/647,734, filed on Jan. 27, 2005. The entire teachings of the above applications are incorporated herein by reference.
The Invention was supported, in whole, or in part by NIH Grant Number 5 UO1 A1058270-02.
Number | Date | Country | |
---|---|---|---|
60574465 | May 2004 | US | |
60583414 | Jun 2004 | US | |
60626597 | Nov 2004 | US | |
60647734 | Jan 2005 | US |